Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Bioorganic & Medicinal Chemistry Letters|August 16, 2025
Synthesis of novel 4/5-substituted 3-arylidene-2-oxindole derivatives and their biological evaluation as NQO2 ligands and NLRP3 downregulatorsElena N Bezsonova, Meriam Dubar, Daria D Melekhina, et al.
Plos Pathogens|December 2, 2025
Polo-like kinase 1 regulates growth in juvenile Fasciola hepaticaPaul McCusker, Nathan G Clarke, Rebecca Armstrong, et al.
The Journal of Biological Chemistry|December 15, 2024
An SH3-binding allosteric modulator stabilizes the global conformation of the AML-associated Src-family kinase, HckAri M Selzer, Gabriella Gerlach, Giancarlo Gonzalez-Areizaga, et al.
European Journal of Biochemistry|September 10, 2004
Differences in substrate specificities between cysteine protease CPB isoforms of Leishmania mexicana are mediated by a few amino acid changesMaria A Juliano, Darren R Brooks, Paul M Selzer, et al.
Chemistry & Biodiversity|September 13, 2024
A Novel Dipterocarpol Derivative That Targets Alpha-Glucosidase and NLRP3 Inflammasome Activity for Treatment of Diabetes MellitusRoman D Danilov, Irina E Smirnova, Zarema I Galimova, et al.
Organic & Biomolecular Chemistry|March 27, 2025
The IMDAV reaction between 3-(isoxazol-3-yl)allylamines and maleic anhydrides: an unusual approach to pyrrolo[3,4-c]pyridine derivatives, possessing anti-inflammatory activityVladimir P Zaytsev, Daria N Simakova, Viktoria S Maslova, et al.
International Journal of Molecular Sciences|October 29, 2025
Genome-Wide Inference of Essential Genes in Dirofilaria immitis Using Machine LearningTúlio L Campos, Pasi K Korhonen, Neil D Young, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2025
Azolo[5',1',2,3]pyrimido[5,4-e]tetrazolo[1,5-c]pyrimidines as dual-action antiglycators and α-glucosidase inhibitorsGrigoriy V Urakov, Konstantin V Savateev, Pavel A Slepukhin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2009
An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancerG Capri, J Chang, S-C Chen, et al.
Bioorganic & Medicinal Chemistry|September 1, 1996
Structure-based design of parasitic protease inhibitorsR Li, X Chen, B Gong, et al.
Pageof 9